Dopamine transporters participate in the physiological regulation of prolactin - PubMed (original) (raw)
Dopamine transporters participate in the physiological regulation of prolactin
J E Demaria et al. Endocrinology. 2000 Jan.
Abstract
Three populations of hypothalamic neuroendocrine dopaminergic (NEDA) neurons, arising from the arcuate and periventricular nuclei of the hypothalamus release dopamine (DA) that acts at the pituitary gland to regulate the secretion of PRL. It is generally accepted that NEDA neurons lack functional DA transporters (DATs), which are responsible for uptake of DA from the synaptic cleft into the presynaptic axon terminal. This study localized DATs to the hypothalamo-pituitary axis and evaluated the effect of DAT blockade on the hypothalamo-pituitary regulation of PRL. After 7 days of treatment with cocaine (a nonspecific amine transporter blocker) or mazindol (a specific DAT blocker), the relative abundance of PRL messenger RNA (mRNA) in the anterior lobe (AL) of OVX rats was significantly decreased, whereas the relative abundance of tyrosine hydroxylase mRNA in the hypothalamus was significantly increased. The effect of cocaine or mazindol administration on DA turnover and serum PRL concentration was examined in estradiol (E2)-treated OVX rats. E2 administration (i.v.) resulted in a significant increase in serum PRL within 4 h; however, cocaine or mazindol administration abolished the E2-induced increase of PRL. Cocaine or mazindol significantly increased the concentration of DA at the site of the axon terminals within the median eminence (ME), intermediate lobe (IL) and neural lobe (NL), indicating blockade of uptake. Because formation of DOPAC requires uptake of DA, concentrations of DOPAC in the ME, IL and NL decreased following treatment with either cocaine or mazindol. These data, together with the presence of immunopositive DAT in the ME, pituitary stalk, IL, and NL, suggest that a functional DAT system is present within all three populations of NEDA neurons. Moreover, similarity between the effects of cocaine and mazindol treatment indicate that blockade of the DAT, but not other amine transporters, is responsible for suppression of PRL gene expression and secretion. Blockade of DATs prevent uptake of DA into NEDA neurons and consequently increases the amount of DA that diffuses into the portal vasculature and reaches the AL. These data provide evidence that DATs play a physiological role in the regulation of DA release from and TH expression in NEDA neurons and consequently PRL secretion and PRL gene expression and further support our previous observation that the regulation of PRL secretion involves all three populations of NEDA neurons.
Similar articles
- Ovarian steroids influence the activity of neuroendocrine dopaminergic neurons.
DeMaria JE, Livingstone JD, Freeman ME. DeMaria JE, et al. Brain Res. 2000 Oct 6;879(1-2):139-47. doi: 10.1016/s0006-8993(00)02763-3. Brain Res. 2000. PMID: 11011015 - Prolactin activates all three populations of hypothalamic neuroendocrine dopaminergic neurons in ovariectomized rats.
DeMaria JE, Lerant AA, Freeman ME. DeMaria JE, et al. Brain Res. 1999 Aug 7;837(1-2):236-41. doi: 10.1016/s0006-8993(99)01667-4. Brain Res. 1999. PMID: 10434008 - The effect of neurointermediate lobe denervation on hypothalamic neuroendocrine dopaminergic neurons.
DeMaria JE, Zelena D, Vecsernyés M, Nagy GM, Freeman ME. DeMaria JE, et al. Brain Res. 1998 Sep 21;806(1):89-94. doi: 10.1016/s0006-8993(98)00740-9. Brain Res. 1998. PMID: 9739113 - Rapid regulation of the dopamine transporter: role in stimulant addiction?
Zahniser NR, Sorkin A. Zahniser NR, et al. Neuropharmacology. 2004;47 Suppl 1:80-91. doi: 10.1016/j.neuropharm.2004.07.010. Neuropharmacology. 2004. PMID: 15464127 Review. - Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration.
Storch A, Ludolph AC, Schwarz J. Storch A, et al. J Neural Transm (Vienna). 2004 Oct;111(10-11):1267-86. doi: 10.1007/s00702-004-0203-2. J Neural Transm (Vienna). 2004. PMID: 15480838 Review.
Cited by
- Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Patients with Schizophrenia: A Randomized Controlled Trial.
Wang Z, Zheng Y, Fan Y, Fan Y, Su X, Wang B, Li J, Chen D, Sun F, Li S, Ma J, Li X, Bai L, Li R. Wang Z, et al. Neuropsychiatr Dis Treat. 2023 Apr 17;19:929-938. doi: 10.2147/NDT.S408314. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 37089913 Free PMC article. Clinical Trial. - Neuroimmunoendocrine Link Between Chronic Kidney Disease and Olfactory Deficits.
Corona R, Ordaz B, Robles-Osorio L, Sabath E, Morales T. Corona R, et al. Front Integr Neurosci. 2022 Jan 31;16:763986. doi: 10.3389/fnint.2022.763986. eCollection 2022. Front Integr Neurosci. 2022. PMID: 35173591 Free PMC article. Review. - A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia.
Osmanova DZ, Freidin MB, Fedorenko OY, Pozhidaev IV, Boiko AS, Vyalova NM, Tiguntsev VV, Kornetova EG, Loonen AJM, Semke AV, Wilffert B, Bokhan NA, Ivanova SA. Osmanova DZ, et al. BMC Med Genet. 2019 Apr 9;20(Suppl 1):47. doi: 10.1186/s12881-019-0773-3. BMC Med Genet. 2019. PMID: 30967134 Free PMC article. - GIRK Channel Activity in Dopamine Neurons of the Ventral Tegmental Area Bidirectionally Regulates Behavioral Sensitivity to Cocaine.
McCall NM, Marron Fernandez de Velasco E, Wickman K. McCall NM, et al. J Neurosci. 2019 May 8;39(19):3600-3610. doi: 10.1523/JNEUROSCI.3101-18.2019. Epub 2019 Mar 5. J Neurosci. 2019. PMID: 30837265 Free PMC article. - Dopamine Release Dynamics in the Tuberoinfundibular Dopamine System.
Stagkourakis S, Dunevall J, Taleat Z, Ewing AG, Broberger C. Stagkourakis S, et al. J Neurosci. 2019 May 22;39(21):4009-4022. doi: 10.1523/JNEUROSCI.2339-18.2019. Epub 2019 Feb 19. J Neurosci. 2019. PMID: 30782976 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources